Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma

Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma

(2018) B. de Unamuno Bustos et al.   BRITISH JOURNAL OF DERMATOLOGY

Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer

(2018) Shao-Ying Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting

(2018) Luciano Pirola et al.   Cancers

Epigenetics of malignant melanoma

(2017) Bruce Moran et al.   SEMINARS IN CANCER BIOLOGY

DNA methyltransferase inhibitors: an updated patent review (2012-2015)

(2016) Pan Xu et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species

(2016) Rebecca M. Harman et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

(2015) Martin Lauss et al.   BMC Medical Genomics

Realizing the promise of cancer predisposition genes

(2014) Nazneen Rahman   NATURE

Emerging trends in the epidemiology of melanoma

(2013) V. Nikolaou et al.   BRITISH JOURNAL OF DERMATOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cytosine methylation profiling of cancer cell lines

(2008) M. Ehrich et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA